Ledger.Open graph →
SEC Form D · filed October 23, 2025

RECODE THERAPEUTICS, INC

Offering
$29.4M
Sold
$29.4M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Menlo Park, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (24)

Patricia S. Millican · Menlo Park, CADirectorShehnaaz Suliman · Menlo Park, CAExec · DirectorEdward S. Hurwitz · Menlo Park, CADirectorAlan S. Colowick · Menlo Park, CADirectorDavid S. Lockhart · Menlo Park, CAExecPeter A. Thompson · Seattle, WADirectorRakhshita S. Dhar · Menlo Park, CADirectorRana S. Al-Hallaq · Menlo Park, CADirectorDean S. Mitchell · Menlo Park, CADirectorBasheer S. Zada · Menlo Park, CADirectorInai S. Park · Menlo Park, CADirectorHelen S. Kim · New York, NYDirectorRana S. Al-Hallaq · Menlo Park, CADirectorPatricia S. Millican · Menlo Park, CADirectorShehnaaz Suliman · Menlo Park, CAExec · DirectorEdward S. Hurwitz · Menlo Park, CADirectorAlan S. Colowick · Menlo Park, CADirectorDavid S. Lockhart · Menlo Park, CAExecDean S. Mitchell · Menlo Park, CADirectorBasheer S. Zada · Menlo Park, CADirectorInai S. Park · Menlo Park, CADirectorHelen S. Kim · New York, NYDirectorPeter A. Thompson · Vancouver, British Columbia, CanadaDirectorRakhshita S. Dhar · Menlo Park, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗